Human Photoallergy Test
NCT02751515 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2016-07-26
Summary
To evaluate the potential of a test material to produce a photoallergic response.
Conditions
- Sunscreening Agents
Interventions
- OTHER
-
Bain De Soliel - Solid
0.05gm/ cm2 of the test article is applied directly to two sites on the skin and covered with the appropriate patch. 24 hours later, the patches are removed. The test sites are lightly wiped with a dry cloth/tissue and 3μl/ cm2 of test article is reapplied directly to the skin of the test site designated for irradiation, and lightly spread over the test site. 48 hours later the procedure is repeated to the same test sites. This process is repeated twice weekly for a total of six exposures.
- OTHER
-
Untreated skin
One site is patched without treatment as control
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- United States
Study Locations
More Related Trials
-
18349-Human Photoallergy Test
NCT02823496 ·Status: COMPLETED ·Phase: NA
-
18348-Human Phototoxicity Test
NCT02823483 ·Status: COMPLETED ·Phase: NA
-
Dermal Photo Allergic Skin Reaction
NCT04070755 ·Status: COMPLETED ·Phase: PHASE1
-
To Test for Photo Allergy Reaction of Sunscreens
NCT02872220 ·Status: COMPLETED ·Phase: NA
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT03015103 ·Status: UNKNOWN ·Phase: NA
-
Photopatch Test Study (POST Study)
NCT03812887 ·Status: UNKNOWN
-
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT00645164 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
NCT04807751 ·Status: COMPLETED ·Phase: PHASE1
-
Penicillin Allergy Testing and Resensitization Rate
NCT03942731 ·Status: COMPLETED
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
NCT02117739 ·Status: COMPLETED ·Phase: PHASE1
-
Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results
NCT06872996 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Influence of Hydrochlorothiazide on Dermal Photosensitivity and DNA Stability - a Pilot Study (HCTox Study)
NCT04654312 ·Status: COMPLETED ·Phase: PHASE1
-
Allergic Disease Onset Prevention Study
NCT05003804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
NCT01518348 ·Status: WITHDRAWN ·Phase: PHASE3
-
Dermatological Assessment of Photoallergy and Phototoxicity
NCT04250623 ·Status: COMPLETED ·Phase: NA
-
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
NCT01085851 ·Status: UNKNOWN ·Phase: PHASE3
-
Diagnosing Drug Allergy: the T is the Key
NCT06409884 ·Status: RECRUITING ·Phase: NA
-
Drug Challenges Without Prior Skin Testing
NCT03158831 ·Status: COMPLETED ·Phase: PHASE1
-
Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.
NCT04332445 ·Status: COMPLETED ·Phase: NA
-
Inter-arm and Inter-period Reproducability of the Dermal Blood Flow Response After a Histamine Skin Prick.
NCT04396977 ·Status: COMPLETED ·Phase: NA
-
The Frequency of Positive Challenge Test to Penicillin in Children Suspected to Have Allergy to Penicillin
NCT02702349 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy
NCT04920721 ·Status: UNKNOWN
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2